Cindy Liu
Director - Molecular Analytical Development Prime Medicine
Cindy Liu, Director of Molecular Analytical Development at Prime Medicine, is an experienced leader in gene and cell therapy analytics. She specializes in sequencing-based methods to characterize rAAV, LNP, and ex vivo cell therapy products, with a focus on ensuring genomic integrity and product quality. Cindy has led analytical development efforts supporting IND-enabling programs and is known for driving cross-functional collaboration across R&D, CMC, and regulatory teams to advance innovative therapies toward the clinic.
Seminars
Tuesday 29th September 2026
Panel Discussion: Advancing Scalable Gene Editing Manufacturing & CDMO Collaboration to Preserve Product Quality & Reduce Timelines
11:30 am
- Streamlining manufacturing and analytical collaboration to preserve product purity, potency, and consistency throughout scale-up
- Optimizing CDMO partnerships and tech transfer strategies to reduce development delays and manufacturing inefficiencies
- Exploring flexible guide RNA manufacturing approaches to support scalable production across diverse rare disease populations
